NAVB logo

NAVB Working Capital

Annual Working Capital

-$6.74 M
-$6.82 M-8169.34%

December 31, 2022


Summary


Performance

NAVB Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBbalance sheetmetrics:

Quarterly Working Capital

-$3.48 M
-$2.17 M-167.07%

September 30, 2023


Summary


Performance

NAVB Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

NAVB Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-8169.3%-167.1%
3 y3 years-645.5%-167.1%
5 y5 years-216.9%-167.1%

NAVB Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-8169.3%at low-4262.4%+56.8%
5 y5-year-471.6%at low-157.8%+56.8%
alltimeall time-114.6%+88.6%-107.5%+94.1%

Navidea Biopharmaceuticals Working Capital History

DateAnnualQuarterly
Sep 2023
-
-$3.48 M(+167.1%)
Jun 2023
-
-$1.30 M(-83.8%)
Mar 2023
-
-$8.05 M(+19.5%)
Dec 2022
-$6.74 M(-8169.3%)
-$6.74 M(+102.2%)
Sep 2022
-
-$3.33 M(-19.7%)
Jun 2022
-
-$4.15 M(+61.1%)
Mar 2022
-
-$2.58 M(-3186.1%)
Dec 2021
$83.50 K(-95.4%)
$83.50 K(-97.7%)
Sep 2021
-
$3.56 M(-40.8%)
Jun 2021
-
$6.02 M(+28.9%)
Mar 2021
-
$4.67 M(+157.5%)
Dec 2020
$1.81 M(-300.6%)
$1.81 M(+132.9%)
Sep 2020
-
$778.50 K(-59.5%)
Jun 2020
-
$1.92 M(-311.6%)
Mar 2020
-
-$907.80 K(+0.4%)
Dec 2019
-$903.80 K(-140.8%)
-$903.80 K(+164.3%)
Sep 2019
-
-$342.00 K(-112.9%)
Jun 2019
-
$2.65 M(-1527.7%)
Mar 2019
-
-$185.80 K(-108.4%)
Dec 2018
$2.22 M(-61.5%)
$2.22 M(+71.4%)
Sep 2018
-
$1.29 M(-34.4%)
Jun 2018
-
$1.97 M(-53.0%)
Mar 2018
-
$4.19 M(-27.3%)
Dec 2017
$5.76 M(-109.8%)
$5.76 M(-37.9%)
Sep 2017
-
$9.28 M(+4.1%)
Jun 2017
-
$8.92 M(-23.9%)
Mar 2017
-
$11.72 M(-119.9%)
Dec 2016
-$59.04 M(-1023.4%)
-$59.04 M(+8.7%)
Sep 2016
-
-$54.33 M(-2.2%)
Jun 2016
-
-$55.54 M(+18.0%)
Mar 2016
-
-$47.06 M(-836.0%)
Dec 2015
$6.39 M(-1486.2%)
$6.39 M(-26.7%)
Sep 2015
-
$8.73 M(-37.4%)
Jun 2015
-
$13.94 M(-385.8%)
Mar 2015
-
-$4.88 M(+957.8%)
Dec 2014
-$461.20 K(-101.8%)
-$461.20 K(-108.2%)
Sep 2014
-
$5.64 M(-60.8%)
Jun 2014
-
$14.41 M(-40.1%)
Mar 2014
-
$24.08 M(-7.5%)
Dec 2013
$26.04 M(+488.2%)
$26.04 M(-37.0%)
Sep 2013
-
$41.32 M(+72.1%)
Jun 2013
-
$24.01 M(+286.8%)
Mar 2013
-
$6.21 M(+40.2%)
Dec 2012
$4.43 M(-83.4%)
$4.43 M(-14.3%)
Sep 2012
-
$5.16 M(-60.6%)
Jun 2012
-
$13.09 M(-29.6%)
Mar 2012
-
$18.59 M(-30.4%)
Dec 2011
$26.70 M(+324.5%)
$26.70 M(-7.0%)
Sep 2011
-
$28.70 M(+349.0%)
Jun 2011
-
$6.39 M(-27.4%)
Mar 2011
-
$8.80 M(+40.0%)
Dec 2010
$6.29 M(+1.2%)
$6.29 M(+154.4%)
Sep 2010
-
$2.47 M(-42.3%)
Jun 2010
-
$4.28 M(-18.6%)
Mar 2010
-
$5.26 M(-15.4%)
Dec 2009
$6.21 M(+26.4%)
$6.21 M(-1.8%)
Sep 2009
-
$6.33 M(+68.1%)
Jun 2009
-
$3.77 M(-16.6%)
Mar 2009
-
$4.52 M(-8.2%)
Dec 2008
$4.92 M
$4.92 M(+76.1%)
Sep 2008
-
$2.79 M(-34.9%)
Jun 2008
-
$4.29 M(+97.8%)
DateAnnualQuarterly
Mar 2008
-
$2.17 M(-12.3%)
Dec 2007
$2.48 M(+28.6%)
$2.48 M(-220.0%)
Sep 2007
-
-$2.06 M(+129.2%)
Jun 2007
-
-$899.70 K(+81.6%)
Mar 2007
-
-$495.40 K(-125.7%)
Dec 2006
$1.92 M(-72.3%)
$1.92 M(-56.5%)
Sep 2006
-
$4.42 M(-23.7%)
Jun 2006
-
$5.80 M(-8.9%)
Mar 2006
-
$6.36 M(-8.5%)
Dec 2005
$6.95 M(-33.4%)
$6.95 M(-11.7%)
Sep 2005
-
$7.87 M(-10.9%)
Jun 2005
-
$8.83 M(-10.6%)
Mar 2005
-
$9.88 M(-5.3%)
Dec 2004
$10.43 M(+315.4%)
$10.43 M(+163.9%)
Sep 2004
-
$3.95 M(-3.1%)
Jun 2004
-
$4.08 M(-1.0%)
Mar 2004
-
$4.12 M(+64.0%)
Dec 2003
$2.51 M(+120.2%)
$2.51 M(+3065.6%)
Sep 2003
-
$79.30 K(-87.5%)
Jun 2003
-
$634.40 K(-5.3%)
Mar 2003
-
$669.90 K(-41.2%)
Dec 2002
$1.14 M(-72.0%)
$1.14 M(-17.8%)
Sep 2002
-
$1.39 M(-41.9%)
Jun 2002
-
$2.39 M(-26.6%)
Mar 2002
-
$3.25 M(-20.1%)
Dec 2001
$4.07 M(+6.9%)
$4.07 M(+0.1%)
Sep 2001
-
$4.07 M(+8.3%)
Jun 2001
-
$3.76 M(+0.9%)
Mar 2001
-
$3.72 M(-2.2%)
Dec 2000
$3.81 M(+281.9%)
$3.81 M(+25.8%)
Sep 2000
-
$3.03 M(+10.4%)
Jun 2000
-
$2.74 M(+16.3%)
Mar 2000
-
$2.36 M(+68.2%)
Dec 1999
$997.00 K(-1.0%)
-
Jun 1999
-
$1.40 M(-46.2%)
Mar 1999
-
$2.60 M(+158.3%)
Dec 1998
$1.01 M(-95.5%)
$1.01 M(-81.4%)
Sep 1998
-
$5.40 M(-44.3%)
Jun 1998
-
$9.70 M(-36.2%)
Mar 1998
-
$15.20 M(-32.0%)
Dec 1997
$22.35 M(-51.5%)
$22.35 M(-15.7%)
Sep 1997
-
$26.50 M(-20.2%)
Jun 1997
-
$33.20 M(-20.2%)
Mar 1997
-
$41.60 M(-9.8%)
Dec 1996
$46.10 M(+169.6%)
$46.10 M(+13.5%)
Sep 1996
-
$40.60 M(-4.0%)
Jun 1996
-
$42.30 M(+183.9%)
Mar 1996
-
$14.90 M(-12.9%)
Dec 1995
$17.10 M(0.0%)
$17.10 M(-6.0%)
Sep 1995
-
$18.20 M(+35.8%)
Jun 1995
-
$13.40 M(+123.3%)
Mar 1995
-
$6.00 M(-64.9%)
Dec 1994
$17.10 M(+92.1%)
$17.10 M(+228.8%)
Sep 1994
-
$5.20 M(+48.6%)
Jun 1994
-
$3.50 M(-39.7%)
Mar 1994
-
$5.80 M(-34.8%)
Dec 1993
$8.90 M(-25.8%)
$8.90 M(+45.9%)
Sep 1993
-
$6.10 M(-28.2%)
Jun 1993
-
$8.50 M(-19.8%)
Mar 1993
-
$10.60 M(-11.7%)
Dec 1992
$12.00 M
$12.00 M(+179.1%)
Sep 1992
-
$4.30 M

FAQ

  • What is Navidea Biopharmaceuticals annual working capital?
  • What is the all time high annual working capital for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals annual working capital year-on-year change?
  • What is Navidea Biopharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals quarterly working capital year-on-year change?

What is Navidea Biopharmaceuticals annual working capital?

The current annual working capital of NAVB is -$6.74 M

What is the all time high annual working capital for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high annual working capital is $46.10 M

What is Navidea Biopharmaceuticals annual working capital year-on-year change?

Over the past year, NAVB annual working capital has changed by -$6.82 M (-8169.34%)

What is Navidea Biopharmaceuticals quarterly working capital?

The current quarterly working capital of NAVB is -$3.48 M

What is the all time high quarterly working capital for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high quarterly working capital is $46.10 M

What is Navidea Biopharmaceuticals quarterly working capital year-on-year change?

Over the past year, NAVB quarterly working capital has changed by -$2.17 M (-167.07%)